This is also the first study to develop the hypothesis that peg-G-CSF-mobilized grafts might have stronger immunomodulatory properties than G-CSF–mobilized grafts, with a reduced incidence of severe grade III-IV acute GVHD possibly mediated by an increased content of MDSCs. This evidence concerns the gene CSF3 and acute graft versus host disease.